Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7345290

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,640,892,000 JPY
-687,837,000 JPY
Interest paid
-3,365,000 JPY
-5,128,000 JPY
Net cash provided by (used in) operating activities
-1,677,464,000 JPY
-708,390,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-11,530,000 JPY
-125,831,000 JPY
Other, net
154,000 JPY
305,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-11,376,000 JPY
-125,696,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-119,988,000 JPY
-211,497,000 JPY
Redemption of bonds
-32,032,000 JPY
-28,028,000 JPY
Net cash provided by (used in) financing activities
1,182,027,000 JPY
367,006,000 JPY
Other, net
-9,290,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
16,865,000 JPY
28,293,000 JPY
Net increase (decrease) in cash and cash equivalents
-489,947,000 JPY
-438,786,000 JPY
Cash and cash equivalents
2,889,101,000 JPY
3,379,048,000 JPY
3,817,834,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.